Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of RAG-17 in Amyotrophic Lateral Sclerosis patients with SOD1 mut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• RAG-17

Snippet

Sponsor: Ractigen Therapeutics. | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: RECRUITING